See also this year's filing and all EDGAR filings for this company.
PDF Report 0001328143_2017_Adamas_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001328143')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001328143, Adamas Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 116,987,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,156,000 |
| 3 | remainder_Assets | 22,330,000 |
| 4 | LiabilitiesCurrent | 9,743,000 |
| 5 | LiabilitiesNoncurrent | 547,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,326,000 |
| 9 | ResearchAndDevelopmentExpense | 31,230,000 |
| 10 | remainder_Expenses | -926,000 |
| 11 | remainder_Revenues | 572,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -35,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 142,473,000 |
| 1 | Liabilities | 10,290,000 |
| 2 | Expenses | 60,630,000 |
| 3 | Revenues | 572,000 |
| 4 | StockholdersEquity | 132,183,000 |
| 5 | NetIncome | -60,058,000 |
| 6 | ComprehensiveNetIncome | -60,075,500 |
| 7 | BaseVar | 107,000,000 |
| 8 | EconomicCapitalRatio | 2.19 |
Edgar->Model Mapping
Feature Distribution
